Treating Acute Leukemia During the COVID-19 Pandemic in an Environment With Limited Resources: A Multicenter Experience in Four Latin American Countries.

JCO Glob Oncol · 2021 · PMC8162972 · PMID 33891480

Europe PMC DOI

hedged sentence

0.0570

closest p · 1.1× alpha

0.0570

boldest claim

The sentences

did not reach statistical significanceP = .057so close (0.05 < p ≤ 0.1)

Patients who developed COVID-19 had a numerically higher rate for disease relapse compared with those who did not develop COVID-19; however, this difference did not reach statistical significance (18.8% v 10.3%; OR 2.01 [95% CI, 1.00 to 4.00]; P = .057).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.